NervGen Pharma Corp (NGEN) NPV
Sell:2.96 CADBuy:3.00 CAD
0.15 CAD
(4.79%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:2.96 CAD
Buy:3.00 CAD
Change:0.15 CAD
(4.79%)
0.15 CAD
(4.79%)Prices delayed by at least 15 minutes
Sell:2.96 CAD
Buy:3.00 CAD
Change:0.15 CAD
(4.79%)
0.15 CAD
(4.79%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 28 March 2024 | PFP BIOSCIENCES HOLDINGS LLC10% Owner | Buy Regular purchase transaction | 2,879,149 | 2.35 CAD | 6,766,000.15 CAD | 2,879,149 |
| 28 March 2024 | William Joseph RadvakChairman of the Board | Buy Regular purchase transaction | 20,000 | 2.35 CAD | 47,000.00 CAD | 1,407,500 |
| 28 March 2024 | Harold Martin PunnettOther Level A | Buy Regular purchase transaction | 25,532 | 2.35 CAD | 60,000.20 CAD | 1,125,532 |
| 28 March 2024 | William James AdamsCFO | Buy Regular purchase transaction | 44,070 | 2.35 CAD | 103,564.50 CAD | 155,820 |
| 28 March 2024 | Michael (Mike) KellyPresident/CEO | Buy Regular purchase transaction | 143,957 | 2.35 CAD | 338,298.95 CAD | 143,957 |
| 28 March 2024 | Glenn Antony IvesDirector | Buy Regular purchase transaction | 8,511 | 2.35 CAD | 20,000.85 CAD | 58,511 |
| 28 March 2024 | John RuffoloDirector | Buy Regular purchase transaction | 42,553 | 2.35 CAD | 99,999.55 CAD | 42,553 |
| 28 March 2024 | Randall KayeDirector | Buy Regular purchase transaction | 10,000 | 2.35 CAD | 23,500.00 CAD | 10,000 |
| 28 March 2024 | Krista McKerracherDirector | Buy Regular purchase transaction | 5,758 | 2.35 CAD | 13,531.30 CAD | 5,758 |
| 11 March 2024 | Brian Eric BayleyIndependent Director | Sell Regular sell transaction (market) | 150,000 | 3.00 CAD | 450,000.00 CAD | 300,000 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 28 March 2024 | PFP BIOSCIENCES HOLDINGS LLC10% Owner | Buy Regular purchase transaction | 2,879,149 | 2.35 CAD | 6,766,000.15 CAD | 2,879,149 |
| 11 March 2024 | Brian Eric BayleyIndependent Director | Sell Regular sell transaction (market) | 150,000 | 3.00 CAD | 450,000.00 CAD | 300,000 |
| 28 March 2024 | Michael (Mike) KellyPresident/CEO | Buy Regular purchase transaction | 143,957 | 2.35 CAD | 338,298.95 CAD | 143,957 |
| 28 March 2024 | William James AdamsCFO | Buy Regular purchase transaction | 44,070 | 2.35 CAD | 103,564.50 CAD | 155,820 |
| 28 March 2024 | John RuffoloDirector | Buy Regular purchase transaction | 42,553 | 2.35 CAD | 99,999.55 CAD | 42,553 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.